Morphochem

German, late clinical stage biopharma developing oxazolidinone antibiotics for clostridium difficile infections

placeMunich, Bavaria, Germany calendar_todayFounded 1998 groups1 employees language morphochem.de

Registered entities

Investor mix

11 investors on record.

Investor typeCountShare
Venture capital545%
Private equity218%
Bank & private debt19%
Other / undisclosed327%
Coming soon